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Thiopeptides are ribosomally synthesized, post-
translationally modified peptides with potent activity
against Gram-positives. However, only GE2270 has
yielded semisynthetic derivatives under clinical in-
vestigations. The pbt gene cluster from the GE2270
producer Planobispora rosea was successfully ex-
pressed in the genetically tractable Nonomuraea
ATCC39727. Gene deletions established that PbtO,
PbtM1, PbtM2, PbtM3, and PbtM4 are involved in
regiospecific hydroxylation and methylations of
GE2270, leading to the generation of various deriva-
tives with altered decorations. Further deletions
established that PbtH and PbtG1 are involved in
C-terminal amide and oxazoline formation, respec-
tively. Surprisingly, preventing either step resulted
in the accumulation of linear precursors in which
the pyridine-generated macrocycle failed to form,
and only one of the pyridine-forming serine residues
had been dehydrated. Often, these linear precursors
present a shortened C terminus but retain the full set
of methylation and hydroxylation decorations.
INTRODUCTION
Thiopeptides represent a large class of microbial metabolites
within the growing family of ribosomally synthesized, posttrans-
lationallymodified peptides (Arnison et al., 2013). They arise from
a precursor peptide containing an N-terminal leader and a core
region, which undergoes the posttranslational modifications
(PTMs) that are the hallmark of this family: the characteristic
thiazoles (Thz) and oxazoles with a central pyridine/piperidine
ring that defines the macrocycle (Arnison et al., 2013; Zhang
and Liu, 2013).
Thiopeptides inhibit bacterial protein synthesis by affecting
either one of two targets: molecules such as thiostrepton and
thiocillins bind to the 23S rRNA/L11 protein interface of the
50S ribosome (Walsh et al., 2010), whereas 29-membered ring
thiopeptides, such as GE37468, GE2270, and thiomuracin,
bind to elongation factor Tu and block its capacity to chaperone
aminoacylated transfer RNAs (tRNAs) to the ribosome (WalshChemistry & Biology 20, 1067–et al., 2010; Parmeggiani et al., 2006). Many thiopeptides exhibit
potent activity against Gram-positive bacteria, including methi-
cillin-resistant Staphylococcus aureus, vancomycin-resistant
Enterococcus sp., and Clostridium difficile. Other thiopeptides
inhibit the 20S proteasome, highlighting their potential as anti-
tumor agents (Bhat et al., 2009). However, the poor solubility
and pharmacological properties of thiopeptides have limited
clinical progress and only derivatives of GE2270 have entered
clinical trials for the topical treatment of acne or of C. difficile-
associated diarrhea (Butler, 2005; Donadio et al., 2010;
LaMarche et al., 2012).
GE2270 is produced by the actinomycete Planobispora rosea
ATCC53733 as a complex of related metabolites differing in the
number of methyl groups that decorate residues in the macro-
cycle, with GE2270A as the main congener carrying a full
set of methyl groups (Selva et al., 1995; Tavecchia et al., 1994)
(Figure 1). Here, we report the identification of the GE2270
biosynthetic gene cluster fromPlanobispora rosea, highly related
to the cluster identified from NonomuraeaWU8817 (Morris et al.,
2009), and its heterologous expression in Nonomuraea sp.
Manipulation of the cluster led to the generation of diverse
GE2270 derivatives, as well as linear and/or C-terminally trun-
cated forms of this thiopeptide. These results provide impor-
tant insights into the checkpoints leading to full thiopeptide
maturation.RESULTS
Expressing the P. rosea GE2270 Biosynthetic Gene
Cluster in Nonomuraea
From a draft genome of P. rosea ATCC53733, we identified a
21.4 kb segment encoding the predicted 14-aa GE2270 core
peptide, preceded by a 39-aa N-terminal leader and followed
by a Ser-Ala C-terminal extension (Figure 1). The P. rosea
GE2270 cluster, named pbt (Planobispora thiopeptide), shows
high sequence identity (ranging from 64% for PbtR to 93% for
PbtA) (Table 1) and complete synteny with the tpd cluster from
the GE2270-producer Nonomuraea WU8817 (Morris et al.,
2009). The only exception is represented by tpdN, encoding a
putative deaminase reductase, which is absent in the pbt cluster
(Table 1). The structural gene pbtA is followed by the six
pbtBCDEFG genes, predicted to represent the cassette respon-
sible for constructing the pyridine ring and the thiazoles charac-
teristic of the thiopeptide scaffold (Arnison et al., 2013). Other1077, August 22, 2013 ª2013 Elsevier Ltd All rights reserved 1067
Figure 1. Organization of the P. rosea pbt Cluster and the GE2270 Complex
(A) The cluster, flanking regions, and span of cosmid 2F7. The deduced functions of coding DNA sequences are summarized in Table 1. The amino acid sequence
of the PbtA core peptide is shown below. Genes rpoC, rpsL, rpsG, fusA, and tuf designate genes encoding RNA polymerase b0, ribosomal proteins S12 and S7,
and elongation factors G and Tu, respectively.
(B) Structure of GE2270 and known congeners. Thiazoles are named A–F as described (Kettenring et al., 1991). Amino acid residues mentioned in the text as
numbered. For simplicity, congener T, an analog of congener A carrying an oxidized oxazoline (Selva et al., 1995), has been omitted.
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nated PbtB1 and PbtG1, respectively, as well as the predicted
P450 monooxygenase PbtO, the methyltransferases PbtM1
through PbtM4, and the NosA homolog PbtH, likely responsible
for terminal amide formation (Yu et al., 2010) (Figure 1; Table 1).
As seen with other thiopeptide clusters (Yu et al., 2009), pbt is
located within a highly conserved region of the genome, with
genes coding for DNA-directed RNA polymerase subunits and
for part of the translation machinery (elongation factors G and
Tu and ribosomal proteins) on the left- and right-hand side of
Figure 1A. It is worth noting that the P. rosea EF-Tu is insensitive
to GE2270 (Sosio et al., 1996).
As no gene transfer systems have been described yet for
P. rosea, we resorted to heterologous expression to analyze
the GE2270 cluster. To this end, we made use of cosmid 2F7,
which carries the entire pbt gene cluster and flanking regions,
including the tuf gene (Figure 1A), on a conjugative vector
capable of site-specific integration in many actinomycete strains
(see Experimental Procedures). Several attempts at GE2270
production in Streptomyces spp. (such as S. lividans, S. albus)
proved unsuccessful (data not shown). However, we succeeded
with Nonomuraea sp. ATCC39727, a microorganism taxonomi-
cally related to P. rosea, amenable to genetic manipulation
(Sosio et al., 2003; Stinchi et al., 2003), and recently used as het-
erologous host for ribosomally synthesized peptides (Foulston
and Bibb, 2010; Sherwood et al., 2013). Methanolic extracts
from one of the Nonomuraea ex-conjugants carrying cosmid
2F7 (designated strain Nono-2F7) exhibited a high-performance1068 Chemistry & Biology 20, 1067–1077, August 22, 2013 ª2013 Elliquid chromatography (HPLC) peak that showed the same
retention time and mass spectrometry (MS) profile as authentic
GE2270A (Figure 2A). No equivalent peak or MS signal was
observed from a Nonomuraea exconjugant (designated strain
Nono-cos3) carrying the empty vector (Figure 2A). In contrast
to Nonomuraea WU8817, the genome of the ATCC39727 strain
does not contain a GE2270 gene cluster (P. Alifano, personal
communication). 1H-NMR analysis of the purified compound
confirmed that the metabolite produced by strain Nono-2F7 is
indistinguishable from GE2270A as produced by P. rosea (data
not shown). These results demonstrate that cosmid 2F7 contains
all the genes necessary for GE2270 production and suggests
that tdpN (Morris et al., 2009) is not essential for thiopeptide
formation. Depending on experimental conditions, congener
C1 was sometimes observed as minor product of Nono-2F7.
Although GE2270 production by Nono-2F7 afforded sufficient
GE2270 (10 mg/l) for characterization, genetic alterations in a
cluster usually result in lower yields of the end product. We
thus analyzed different growth media for increased GE2270
levels. As shown in Figure 2B, improved media resulted in over
20-fold increase in production, up to 250 mg/L. Interestingly,
GE2270 production by Nono-2F7 followed a time course similar
to that observed, under nonoptimized conditions with the
P. rosea native producer, with production starting during the
exponential growth phase (Figure 2C).
Because Nonomuraea produces the glycopeptide A40926
(Sosio et al., 2003), we made use of a glycopeptide intermedi-
ate-resistant S. aureus (GISA) strain for analyzing Nonomuraeasevier Ltd All rights reserved
Table 1. List of Pbt Proteins
CDS Size (aa) Tpd Homolog (Identity; %) Proposed Function Established Role in GE2270 Biosynthesis
PbtR 237 TpdR (64) transcriptional regulator
PbtG1 607 TpdO (83) YcaO cyclodehydratase oxazoline formation
PbtB1 792 TpdP (71) dehydratase
PbtO 344 TpdQ (80) P450 monooxygenase b-hydroxylation of Phe8
PbtX 215 TpdS (80) hypothetical protein
PbtM1 372 TpdT (92) N-methyltransferase N-methylation of Asn4
PbtM2 394 TpdU (88) radical SAM protein C-methylation of ThzE
PbtA 55 TpdA (93) precursor peptide
PbtB 829 TpdB (73) lantibiotic dehydratase
PbtC 302 TpdC (72) lantibiotic dehydratase
PbtD 333 TpdD (78) [4 + 2] cycloaddition
PbtE 456 TpdE (80) azoline-synthesizing dehydrogenase
PbtF 598 TpdF (73) hypothetical protein
PbtG 578 TpdG (84) YcaO cyclodehydratase essential
PbtH 122 TpdK (86) hypothetical (NosA) C-terminal amide formation
PbtM3 388 TpdL (86) radical SAM protein C-methylation of ThzD
PbtM4 335 TpdM (83) O-methyltransferase ThzD O-methyltransferase
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strain when spotting Nono-2F7 cultures, whereas no effect
was seen with cultures from the control strain Nono-cos3, car-
rying the empty vector (Figure 2D). In contrast, cultures from
the Nono-cos3 strain inhibited growth of glycopeptide-sensitive
strains, such as B. subtilis ATCC6633 (GE2270S) or its derivative
G1674 (GE2270R) (Sosio et al., 1996), presumably due to the
presence of the glycopeptide A40926 (Figure 2D).
In order to analyze the function of pbt genes, we performed
targeted gene deletions. This was achieved by l Red recombin-
eering of cosmid 2F7, replacing selected genes with an antibiotic
resistance marker (cat or kan) flanked by FRT sites (Table S1
available online). In some cases, the resistance marker was
excised via flippase (FLP)-mediated recombination (Table S1).
The modified cosmids were then transferred by conjugation
into Nonomuraea ATCC39727 and the resulting metabolites
were characterized by HPLC, MS, and nuclear magnetic reso-
nance (NMR) analyses. Routinely, two independent ex-conju-
gantswere analyzed formetabolite content, alwayswith identical
results. Identity of compoundswas established by a combination
of HPLC, MS, and NMR analyses, unless stated otherwise.
Modulating the GE2270 Complex
A distinguishing feature of GE2270 is the pattern of methylations
that decorate the Asn (N-methyl), ThzE (C-methyl), and ThzD
(C-methylene-O-methyl) residues. The presence or lack of these
substitutions is reflected in the knownGE2270 congeners, which
do not, however, encompass all possible permutations at these
residues (Figure 1B). As suggested by the predicted functions,
pbtM1 and pbtM4 are the likely candidates for N- andO-methyl-
ation, respectively, whereas pbtM2 and pbtM3 encode radical
SAM enzymes expected to be responsible for C-methylation of
the thiazoles.
To confirm its function, we replaced pbtM1 in cosmid 2F7
with kan. The resulting ex-conjugant Nono-M1 produced the
expected GE2270 B1 congener, lacking the N-methyl group, inChemistry & Biology 20, 1067–80%, with smaller amounts of the D1 congener, the C-des-
methyl derivative of B1 on Thz D (Figure 3A; Table S1). Similarly,
strain Nono-M4 carries cosmid 2F7 in which pbtM4 has been
replaced by kan. This strain yielded a single compound identified
as the O-desmethyl GE2270 congener D2 (Figure 3B; Table S1).
These data confirm the roles of PbtM1 and PbtM4 as the N- and
O-methyltransferases acting on Asn4 and ThzD, respectively
(Table 1).
Labeled precursor studies (De Pietro et al., 2001) and the gene
encoding the precursor peptide (Morris et al., 2009) indicate that
all thiazoles arise from Cys residues and subsequent C-methyl-
ation of the appropriate residues. After replacing pbtM3 or
pbtM2 with cat in cosmid 2F7, the ex-conjugants Nono-M3 or
Nono-M2 were obtained, respectively. The former strain pro-
duced a major compound identified as the C1 congener, which
carries a desmethylated ThzD moiety (Figure 3C; Table S1).
Conversely, strain Nono-M2 produced in 65% yield a compound
whose HPLC retention time and MS data were indistinguishable
from those of the C2b congener and NMR confirmed the pres-
ence of a desmethylated ThzE (Figure 3D; Table S1). Interest-
ingly, strain Nono-M2 produced an additional peak (35% yield)
with m/z of 1,284 [M + Na]+. Further MS and NMR analyses
(Table S2) established that this peak corresponds to a previously
unreported congener (compound 1) devoid of methyl groups on
ThzE and Asn (Figure 3D). All together, these data demonstrate
that PbtM2 and PbtM3 are involved in the regioselective
C-methylation of ThzE and ThzD, respectively (Table 1).
Upstream to pbtM1 is pbtX, encoding a protein of unknown
function with no counterpart in other thiopeptide clusters.
Replacing pbtX with cat in cosmid 2F7 yielded strain Nono-X,
which showed an LC-MS profile indistinguishable from that of
Nono-M1: the two major peaks were the known congeners
B1 and D1 (Table S1). Because we cannot exclude polar effect
of the mutations introduced into pbtX on pbtM1 expression, it
remains to be determined whether PbtX has any role in methyl-
ation of Asp4 together with PbtM1.1077, August 22, 2013 ª2013 Elsevier Ltd All rights reserved 1069
Figure 2. Heterologous Production of GE2270 in Nonomuraea
(A) HPLC trace (l 310 nm) of methanolic extracts from strains carrying cosmid 2F7 (Nono-2F7) or empty vector (Nono-cos3) with respect to a standard of pure
GE2270A.
(B) Production of GE2270 by Nono-2F7 in differentmedia. Production levels were established by HPLC after 6 days of growth in eachmedium, using two replicate
flasks. Error bars represent SEM.
(C) Biomass and GE2270 production in native versus heterologous host. Dry weight (dashed lines) and GE2270 levels (solid lines) were determined for P. rosea
(squares) and Nono-2F7 (triangles).
(D) Antibacterial overlay assay. Samples (10 ml) from cultures of Nonomuraea ATCC39727 (spot 1), Nono-cos3 (spot 3), and Nono-2F7 (spot 4) were spotted on
MH agar plates inoculated with the indicated microorganism. GE2270A (spot 2) was used as control.
See also Tables S1 and S4.
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Genetic Intervention
The pbtO gene encodes a P450 monooxygenase likely respon-
sible for Phe8 b-hydroxylation. This genewas replaced in cosmid
2F7 by cat, which was then excised by the FLP recombinase.
The resulting Nonomuraea ex-conjugant, designated strain
Nono-O, produced two GE2270-related peaks (compounds 2
and 3) in a 1:1 ratio with positively charged MS signals at m/z
1,260 and 1,274 [M + H]+ (Figure 4A; Table S1), with an MS frag-
mentation pattern consistent with GE2270 derivatives devoid of
the Phe8 hydroxyl. NMR analyses (Figures S1 and S2; Table S2)
established that compound 2 corresponds to a GE2270
congener with a full set of methylations on Asn4, ThzD, and
ThzE but carrying an unmodified Phe8 residue, whereas 3 is its
ThzD-O-desmethyl derivative (Figure 4A). These data demon-
strate that PbtO is the monooxygenase responsible for b-hy-
droxylation of Phe8 and suggest that O-methylation of ThzD
may be less efficient on substrates devoid of a Phe-8 b-hydroxyl.
The ribosomal origin of thiopeptides offers the possibility of
altering the amino acid sequence by engineering the structural
gene. Such efforts have been applied to produce thiocillin (Acker
et al., 2009; Bowers et al., 2010, 2012), thiostrepton (Li et al.,
2012), and GE37468 variants (Young and Walsh, 2011). A thor-1070 Chemistry & Biology 20, 1067–1077, August 22, 2013 ª2013 Elough analysis of replacing most amino acid residues in the
core peptide showed that substitutions can be obtained at few
residues in GE37468 (Young et al., 2012). To establish whether
substitutions are possible in GE2270, we focused on residues
Val5 and Gly7, which are not involved in setting the trithiazolyl-
pyridine core in the mature scaffold and thus unlike to perturb
the thiopeptide framework. The core peptide variants G7A,
G7K, or V5Ewere constructed and introduced intoNonomuraea,
generating strains Nono-G7A, Nono-G7K, and Nono-V5E,
respectively. Methanolic extracts from Nono-G7A showed an
HPLC peak with m/z 1,344 [M + Na]+ compatible with com-
pound 4, carrying the desired Ala-replacement at position 7 (Fig-
ure 4B; Table S1). However, no metabolites were detected from
strains Nono-G7K and -V5E, suggesting that the introduced
mutations adversely affect thiopeptide formation.
Perturbing Pyridine, Oxazoline, and C-Terminal Amide
Formation
Similarly to other thiopeptides, the C terminus of GE2270 is ami-
dated, which implies that the amino acid residues Ser15 and
Ala16 present in the precursor peptide are somehow removed
during thiopeptide maturation. Recent studies have shown that
two divergent strategies are utilized for C-terminal amidationsevier Ltd All rights reserved
Figure 3. Production of GE2270 Congeners in Nonomuraea
HPLC traces (l 310 nm) of extracts from strains Nono-M1 (A), Nono-M4 (B), Nono-M3 (C), and Nono-M2 (D). Dashed lines indicate the retention time of GE2270A.
The known congeners are reported according to their codes (Figure 1B), whereas the identified congener is indicated as ‘‘1’’. Structures of the relevant part of
GE2270 are also shown for convenience with grey circles indicating the affected position.
See also Tables S1 and S2.
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Liao and Liu, 2011; Liu et al., 2013). Because the pbt cluster
encodes the NosA-homolog PbtH, we assumed that amide
formation in GE2270 results from a mechanism that is similar
to the nosiheptide mechanism, in which nosA deletion yielded
a nosiheptide analog with an additional C-terminal dehydroala-
nine, resulting from dehydration of the C-terminal Ser in the
core peptide (Liu et al., 2013). After replacing pbtH with cat in
cosmid 2F7, the resulting exconjugant Nono-H produced, in a
relative ratio of 70:30, compounds 5 and 6 with m/z 1,291 and
1,345 [M + H]+, respectively (Figure 5A; Table S1). NMR analysis
established that compound 5 is an analog of congener A,
whereas LC-HRMS gave m/z 1,291.2557 [M + H]+ (calculated
for C56H55N14O11S6, 1,291.2493) confirming that compound 5
contains aC-terminal carboxylic acid in place of the amide. Quite
surprisingly, compound 6 lacked the UV adsorption and MS
fragmentation pattern typical of GE2270 congeners. NMR ana-
lyses established that 6 is an acyclic precursor of 5 devoid of
the pyridine ring, but containing an N-terminal methyl ketone
(in place of Ser1) and an unmodified Ser11 (Figure S3; Table
S3) (LC-HRMS m/z 1,345.2891 [M + H]+; calculated for
C56H60N14O14S6, 1,345.2814). Interestingly, compound 6 carries
the full set of methylations and hydroxylations seen in the final
product (Figure 5A).
In thiopeptides, a YcaO-like cyclodehydratase is proposed to
catalyze the nucleophilic addition of eachCys (for thiazole) or SerChemistry & Biology 20, 1067–(for oxazole) side chain onto the preceding carbonylic group,
which is followed by phosphorylation-based dehydration to
afford the azoline ring (Dunbar et al., 2012; Arnison et al.,
2013). The pbt cluster contains two such homologs: pbtG in
the highly conserved thiopeptide gene cassette, and pbtG1
upstream to pbtA (Figure 1). On the basis of its location and
sequence identity, PbtG is likely to be involved in thiazole forma-
tion, whereas PbtG1 may catalyze the less efficient oxazoline
formation (Belshaw et al., 1998). We thus replaced pbtG or
pbtG1 in cosmid 2F7 by marker insertion followed by FLP
recombinase excision. The resulting exconjugants, designated
Nono-G or Nono-G1, respectively, were analyzed for metabolite
content. Although no peak was observed from the Nono-G
strain, two peaks in a 70:30 ratio with m/z values of 1,222 [M +
H]+ (compound 7) and 1,266 [M + H]+ (compound 8) were
detected from the Nono-G1 strain (Figure 5B; Table S1). NMR
analyses revealed that both 7 and 8 are linear forms in which
all the thiazoles are present, but differ from GE2270 for the
following features: (1) no oxazoline but intact Ser13, (2) intact
Ser11 and methyl ketone (after Ser1) instead of the pyridine
ring, and (3) a shorter peptide lacking the C-terminal Pro-amide
(Figures 5B and S4–S10; Table S3). Interestingly, compound 8
carries the full set of methylations and hydroxylations, whereas
7 lacks the methoxymethyl on ThzD. All together, these results
point to a specific role of PbtG1 in oxazoline formation, a reaction
that cannot be substituted for by PbtG, which is, instead,1077, August 22, 2013 ª2013 Elsevier Ltd All rights reserved 1071
Figure 4. GE2270 Variants
HPLC traces (l 310 nm) of extracts from strains Nono-O (A) and Nono-G7A (B). Dashed lines indicate the retention time of GE2270A. Structures of the relevant
part of GE2270 in compounds 2, 3, and 4 are also shown with gray circles indicating the affected position.
See also Figures S1 and S2 and Tables S1 and S2.
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its role in thiazole formation (Table 1).
Next, we investigated the role of the Ser-Ala C terminus in
correct C-terminal processing. Cosmid 2F7 was suitably engi-
neered by deleting the last two codon from pbtA. The resulting
ex-conjugant Nono-AD2 presented an HPLC profile with two
major peaks in a 80:20 ratio with identical retention times and
m/z values to 7 and 8 (Figure 5B; Table S1), as confirmed also
by NMR analyses (Table S3). Furthermore, strain Nono-AD2
produced also a smaller amount of compound 5. These data
suggest that the presence of Ser15-Ala16 at the C terminus is
critical not only for amide formation but also for cyclization
of Ser13 into an oxazoline. Consistently, when either of these
events is impaired, pyridine formation can no longer occur.
Overall, four additional, fully cyclized GE2270 variants were
obtained in the course of this work. Their antibacterial activities,
measured as minimum inhibitory concentrations (MIC) against
selected strains are shown in Table 2. Although these com-
pounds appear less potent than GE2270A, in particular they
lose activity mostly against Streptococcus spp., they all retain
interesting activities, particularly against Enterococcus faecalis.
DISCUSSION
The results presented in this study provide important insights
into the biosynthesis of GE2270 and other thiopeptides. A
key tool for this work has been heterologous expression in
Nonomuraea ATCC39727. Foulston and Bibb (2010) have shown
that this strain is a suitable host for expressing class I lantibiotics
from the related genera Microbispora and Planomonospora
(Sherwood et al., 2013), but have not used it for systematic clus-
ter analysis. Here, we have shown that Nonomuraea is a robust
host for expression, because each manipulation involved intro-
ducing modified cosmids into a ‘‘naive’’ host, followed by anal-1072 Chemistry & Biology 20, 1067–1077, August 22, 2013 ª2013 Elysis of two independent ex-conjugants. We reliably observed
comparable levels of metabolites.
After the discovery of GE2270 (Selva et al., 1991), an extensive
search for and characterization of the congeners present in the
complex was performed (Selva et al., 1995; Colombo et al.,
1995). However, details were not reported on the conditions
under which the various compounds were obtained and their
relative yields. In the work presented here, we have established
that five specific enzymes are involved in the four methylations
and the hydroxylations that decorate the GE2270 scaffold, but
none of these reactions is a requirement for subsequent steps
to occur. This is particularly remarkable in the case of PbtO,
becausewewere able to isolate deoxy-Phe congeners (Figure 1).
These results suggest that PbtO-mediated hydroxylation occurs
quite effectively in vivo, preventing the accumulation of detect-
able amounts of deoxy-Phe variants; they are also reminiscent
of another P450-catalyzed hydroxylation, in which deoxy-eryth-
romycin analogs were discovered only after inactivation of the
corresponding gene (Weber et al., 1991). Similarly, the identifica-
tion of the previously unreported congener 1, after inactivation of
the C-methyltransferase PbtM2, suggests that N-methylation
in vivo occurs preferentially on a methylated ThzE, although we
cannot exclude a polar effect on pbtM1. Finally, our results point
to the lack of additional pbt genes as candidates for installing the
oxygen atom on ThzD. Thus, either a host enzyme presents in
both P. rosea and Nonomuraea is responsible for hydroxylation
of methyl-ThzD or one of the Pbt enzymes might be able to carry
this additional modification. Currently, we are inclined to believe
that the GE2270 B2 congener (Figure 1B) represents a shunt
product and not a true biosynthetic intermediate.
We have demonstrated that oxazoline formation in GE2270
requires the dedicated YcaO-like cyclodehydratase PbtG1 and
that processing of the Pro-Ser-Ala C terminus of the core peptide
into Pro-NH2 requires the NosA-homolog PbtH. An unexpectedsevier Ltd All rights reserved
Figure 5. GE2270 Linear Intermediates and C-Terminal Variant
HPLC traces (l 310 nm) of extracts from strains Nono-H (A) and Nono-G1 and Nono-AD2 (B). Dashed lines indicate the retention time of GE2270A. Structures of
the relevant part of GE2270 in compounds 5, 6, 7, and 8 are also shown with gray circles indicating the affected position.
See also Figures S3–S10 and Tables S1 and S3.
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linear variants 6–8 devoid of the pyridine ring. In these com-
pounds, Ser13 is still unmodified, whereas Ser1 has yielded
the N-terminal methylketone appendage on ThzF, presumably
after dehydration and removal of the leader peptide. These re-
sults are consistent with and complement the recent observa-
tions by Malcomson et al. (2013) in berninamycin biosynthesis:
these authors observed the accumulation of linear intermediates
in which the pyridine-forming C-terminal Ser is still intact and
speculated that a dedicated dehydratase may trigger pyridine
ring formation by selectively intervening on that Ser residue after
some key events have occurred in thiopeptide maturation.
Although Malcomson et al. (2013) observed the berninamycin
linear variants after amino acid substitutions in the core peptide
that is contained within the final macrocycle, we have shown that
oxazoline formation is an essential checkpoint along GE2270
maturation before pyridine ring closure can occur. The presence
of a properly processed C terminus seems also an important
requisite before macrocyclization can take place, because linear
intermediates formed to a significant extent in the DpbtH strain
and exclusively in the pbtA-D2 mutant.
Overall, the results presented here allow us to propose a plau-
sible order of biosynthetic reactions (Figure 6). The first step on
the precursor peptide maturation is likely to be thiazole forma-
tion; this is followed by the PbtG1-catalyzed oxazoline synthesis;
subsequent steps are C-terminal amide installment, catalyzed
by PbtH; and finally pyridine ring generation, with macrocycle
formation. Along this hypothetical scheme, wewould like to point
out that most linear intermediates observed in this study carry aChemistry & Biology 20, 1067–full set of decorations on Phe8, ThzD, ThzE, and Asn4. This
observation indicates that these reactions can occur on linear
intermediate(s), presumably after the thiazole rings have been
formed (Figure 6).SIGNIFICANCE
This work provides important insights into the biosynthesis
of the thiopeptide GE2270. It shows some flexibility by the
synthetic machinery in accepting substitutions in the core
peptide. Most importantly, it shows that linear intermediates
accumulate when oxazoline formation is prevented and
when the C terminus is altered, which suggests these events
are important checkpoints before macrocyclization. These
linear intermediates retain an intact Ser13 residue, which
suggests that regioselective dehydration of this serine is a
late event in thiopeptide maturation. We have also demon-
strated the role of the methyltransferases and monooxyge-
nases encoded by the pbt cluster in the regioselective
modification of their cognate residues. Remarkably, these
modifications can also occur on linear intermediates. All
these observations provide in vivo evidence for the order
of steps that lead to thiopeptide formation.EXPERIMENTAL PROCEDURES
Bacterial Strain and Growth Conditions
All bacterial strains used in this study were from the Naicons collection, except
for Bacillus subtilis ATCC6633 and S. aureus ATCC 29213. B. subtilis G16741077, August 22, 2013 ª2013 Elsevier Ltd All rights reserved 1073
Table 2. MICs of GE2270 Congeners Produced in This Study
Microorganisms
MIC (mg/ml)
GE2270A Compound 2 Compound 3 Compound 4 Compound 5
Staphylococcus aureus ATCC 29213 <0.015 0.50 4 0.07 0.50
Streptococcus pyogenes L49 0.25 >32 >16 12.5 4
Streptococcus pneumoniae L44 <0.08 >32 >16 12.5 4
Enterococcus faecalis L559 <0.004 0.125 0.25 0.015 0.125
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Intermediates along GE2270 Biosynthesishas been previously described (Sosio et al., 1996). Planobispora rosea
ATCC53733 and Nonomuraea sp. ATCC39727 were propagated on BTT
agar (Sosio et al., 2003) and seed cultures were made in D/seed (Gastaldo
and Marinelli, 2003) and RARE3 (Sosio et al., 2003) media, respectively. For
GE2270 production, a 72 hr P. rosea culture was inoculated (10%) into V6
broth (Binz et al., 2010). For optimized production in Nonomuraea, the
following media were used: M8_20 (20 g/l dextrose, 20 g/l soluble starch, 4
g/l casein hydrolysate, 2 g/l yeast extract, 2 g/l meat extract, 3 g/l CaCO3,
pH 8.0), Medium C (35 g/l soluble starch, 10 g/l dextrose, 5 g/l casein hydro-
lysate, 3.5 g/l meat extract, 8 g/l yeast extract, 3.5 g/l soybean meal, 2 g/l
CaCO3, pH7.2); and Medium C1 (Medium C containing 20 g/l yeast extract
and 10 g/l soybean meal). All cultures were incubated at 30C and 200 rpm
on a rotary shaker.
Escherichia coli strains XL1Blue and DH10B were used as general cloning
hosts and ET12567/pUB307 as the donor strain in conjugations. The E. coli
strains were cultured in LB medium at 37C, with the appropriate selection
(50 mg/ml ampicillin, 50 mg/ml apramycin, 12.5 mg/ml tetracycline, 25 mg/ml
kanamycin, or 25 mg/ml chloramphenicol).
For dry weight determinations mycelium from 7 ml culture was separated
from broth by filtration on a preweighted filter membrane. The mycelium was
dried with the filter for 24 hr at 37C.
Cosmid Library Construction and Identification of pbt Cluster
Genomic DNA was extracted from P. rosea ATCC53733, grown in seed me-
dium for 3 days, according to described procedures (Kieser et al., 2000).
Genomic DNA was digested Sau3AI, purified and ligated into the BamHI site
of the Supercos3 vector (Figure S11). The cosmid library was constructed
using the Gigapack III XL Packaging Extract kit (Stratagene), following the
manufacturer’s instructions. Pools of cosmid-carrying colonies were PCR-
screened with primers specific for pbtR, pbtB, and pbtM3. Cosmid 2F7 re-
sulted positive to all PCR analyses. Sequencing of 2F7 insert ends established
that it contains the entire pbt cluster. The sequence of the pbt cluster is avail-
able at GenBank under accession number KF366381.
GE2270 Heterologous Production
Cosmid2F7was introduced inE. coliET12567/pUB307, and the resulting strain
was used for conjugation with Nonomuraea ATCC39727 as described (Stinchi
et al., 2003) with minor modifications: during mating experiments, donor and
recipient cells were mixed in a 1:1 ratio and plated on MV0.1X agar (2.4 g/l sol-
uble starch, 0.1 g/l dextrose, 0.3 g/l beef extract, 0.5 g/l yeast extract, 0.5 g/l
tryptose, 10mMMgCl2, and 15 g/l agar; pH7.2). After 20 hr at 28
C, each plate
was overlaid with 3 ml soft agar containing 200 mg nalidixic acid and 250 mg
apramycin and further incubated at 28C.Nonomuraea colonies, which usually
appeared after 7–10 days, were streaked on BTT plates containing 25 mg/ml
nalidixic acid and 20 mg/ml apramycin. After PCR confirmation of the presence
of the pbt cluster using primers specific for pbtR, pbtA, and pbtM3, two inde-
pendent colonies were grown and extracted with 2 volumes of methanol.
Following 1 hr at 40C and centrifugation, 20 ml of the resulting supernatant
was analyzed by HPLC on a Shimadzu instrument as described below.
For GE2270 production, 450 ml samples of P. rosea and Nono-2F7 cultures
were withdrawn every 24 hr and processed as described. Production was
quantified by integrating peaks corresponding to GE2270A, using an authentic
sample of GE2270A as external standard.
Manipulation of the pbt Cluster
Gene inactivations in cosmid 2F7 were performed using the l Red recombina-
tion system (Datsenko and Wanner, 2000). Appropriate DNA fragments were1074 Chemistry & Biology 20, 1067–1077, August 22, 2013 ª2013 ElPCR-generated using 70-nt-long primers (Table S4) that included 50-nt exten-
sions to the cognate pbt region and 20-nt priming sequences for pKD3 or
pKD13, for inclusion of kan or cat flanked by FRT sites, respectively. After
purification, each PCR product was used for electroporation of E. coli cells
carrying cosmid 2F7 and Red helper plasmid. The resulting colonies were
examined for the intended recombination product by PCR analysis using
flanking locus-specific primers with the respective kan- or cat-specific
primers.
For the generation of pbtA variants, the l Red recombination system was
modified using forward primers carrying the desired mutations in the 70-nt
pbtA segment (Table S4). The correctness of the PCR products was confirmed
by DNA sequencing. Site-specific recombination to remove kan or cat was
performed using the FLP recombinase provided with plasmid 707-FLPe-tet
(GeneBridges), according to the manufacture’s protocol. The identity of all
mutant cosmids was confirmed by PCR.
Antibacterial Assays
Agar diffusion assays were performed by spotting 10 ml of cultures or metha-
nolic extracts on AntibioticMedium 1 orMu¨ller Hinton (MH) agar plates respec-
tively inoculated with 105 CFU/mL of B. subtilis or S. aureus strains. Plates
were incubated for 16 hr at 37C.
MICs were determined by the broth microdilution methodology in sterile
96-well microtiter plates according to Clinical and Laboratory Standards Insti-
tute guidelines, using MH broth containing 20 mg/l CaCl2 and 10 mg/l MgCl2
for all strains, except forStreptococcus spp., whichwere grown in ToddHewitt
broth (Difco Laboratories). Bacteria were inoculated at 5 3 105 CFU/ ml and
incubated for 24 hr at 37C. The MIC was defined as the lowest drug concen-
tration causing complete suppression of visible growth.
LC-MS Analyses and NMR Spectroscopy
HPLC analyses were performed using an LC 2010A-HT liquid chromatogra-
pher (Shimadzu) equipped with a LiChrosphere C18 5 mm, 4.6 3 100 mm
column (Merck). Elution was performed at 1 ml/min and 50C with a linear
gradient from 10% to 90% phase B in 30 min. Phase A was 0.1% TFA (v/v)
in water and phase B was acetonitrile. UV detection was set at 270 and
310 nm. LC-MS analysis were performed with an Agilent 1100 series liquid
chromatographer equipped with a Ascentis express Supelco RP18, 2.7 m
50 3 4.6 mm column eluted at 1 ml/min at 40C. Elution was with a 10 min
multistep program that consisted of 5%, 95%, 100%, and 5% phase B1 at
0, 6, 7, and 7.2 min, respectively (phases A1 and B1 were 0.05% TFA [v/v] in
water and acetonitrile, respectively) with detection at 220 nm. The effluent
from the column was split 1:1 into a photodiode array detector and into the
ESI interface of a Bruker Esquire 3000 plus ion trap mass spectrometer
(Bruker). Mass spectrometry analyses were performed using as sample inlet
conditions: sheath gas (N2) 50 psi, dry gas 10 l/min, capillary heater 365
C;
as sample inlet voltage settings: positive polarity, capillary voltage 4,000 V,
end plate offset 500 V; as scan conditions: maximum ion time 200 ms, ion
time 5 ms, full micro scan 3; as segment: duration 10 min, scan events positive
(100–2,400 m/z). LC-HRMS analyses were performed on a Surveyor Accela
HPLC system (Thermo Fisher Scientific) connected to an Exactive benchtop
mass spectrometer (Thermo Fisher Scientific), equipped with a NSI-ESI ion
source. Samples were injected on a C8 reversed phase column (BioBasic
C8, 100 3 0.18 mm, 5 mm, 300 A˚, Thermo Fisher Scientific) and eluted with
the following eluent B2 gradient: 5% for 3 min; 5% to 65% in 17 min; and
65% to 95% in 5 min (eluents A2 and B2 were 0.1% formic acid in water and
acetonitrile, respectively); the flow rate was 100 ml/min split in order to achieve
a final flux of 2 ml/min.sevier Ltd All rights reserved
Figure 6. Schematic Representation of Proposed Order of GE2270 Biosynthetic Events
Summary of the experimental evidence that is the likely order of events: thiazole syntheses, oxazoline formation, C-terminal amide installment, and pyridine-
mediatedmacrocyclization. Please note that the timing of leader peptide removal has been arbitrarily placed before pyridine formation. Dashed arrows stemming
from PbtM1-4 and PbtO indicate possible additional substrates for these tailoring steps. Thiazoles and oxazoline are symbolized by gray and dark gray pen-
tagons, respectively; and the pyridine ring by a hexagon. The black circle represents Ser1, which is likely to undergo dehydration at some stage before Ser11.
Only Ser1 and Ser 11 are numbered in the core peptide. LP indicates the leader peptide.
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Intermediates along GE2270 Biosynthesis1H-,13C-, 1D, and 2D NMR spectra (COSY, TOCSY, HSQC, HMBC) were
measured in dmso-d6 or acetone-d6 at 25
C using an AMX 600 MHz spec-
trometer (Bruker). Chemical shifts are reported relative to dmso-d6 (d 2,50)
or acetone-d6 (d 2,05).
Production and Isolation of Compounds from Nonomuraea
The culture (1 l) was centrifuged at 3,000 rpm for 10 min and the mycelium was
extracted overnight with 240 ml methanol on a rotary shaker at room temper-
ature. After centrifugation, the exhausted mycelium was discarded and the
methanolic extract was concentrated under vacuum to 20 ml and transferred
into a separating funnel, where an equal volume of butanol was added along
with few mL H2O. The resulting butanol phase was evaporated to dryness,
dissolved in 2 ml dichloromethane, and purified by medium pressure chroma-
tography on a 12 g normal phase silica Flash RediSep RF column using a
CombiFlash RF Teledyne Isco Medium Pressure Chromatography System.
The silica was previously conditioned for 2 min at 30 ml/min with dichlorome-
thane, then brought to 50% methanol within 13 min. The fractions containing
the desired compound were pooled and concentrated under vacuum. This
procedure was used to purify GE2270 congeners A, B1, C1, D1, D2, C2b,
and compounds 1 and 4.
For compounds 2 and 3, 1 l culture was processed as above up to the meth-
anolic extract, which was evaporated to 50ml and split into 53 10ml portions,
each purified using a 5 g Flash C18 prepacked column (Isolute, Biotage)
placed on a Vac Master system (Stepbio). Each loaded solution was washed
with 10 ml acetonitrile:water 25:75 and eluted with 15 ml acetonitrile:water
75:25. Fractions were pooled, evaporated to dryness, dissolved in 1 ml aceto-Chemistry & Biology 20, 1067–nitrile:water 75:25 and fractionated by HPLC using a Shimadzu Series 10
system equipped with a LiChrosphere C18 5 mm, 4.6 3 100 mm reversed-
phase column (Merck) and a 22 min linear gradient from 10% H2O to 80%
acetonitrile.
For compounds 5 and 6, cultures were centrifuged at 3,000 rpm for 10 min.
The mycelium was processed as above up to the methanolic extract, which
was concentrated to 7 mL. This sample was fractionated by medium pressure
chromatography on 30 g reversed phase Biotage Snap Cartridge KP-C18-HS
by using a CombiFlash RF Teledyne Isco Medium Pressure Chromatography
System. The column was previously conditioned for 1 min at 20 ml/min with
H2O, then brought successively to 40% acetonitrile in 5 min, to 60% acetoni-
trile in 13 min, and finally washed for 2 min with 95% acetonitrile. Fractions
containing compound 5 were pooled and concentrated under vacuum and
subjected to LC-MS analysis as described above. The supernatant was
extracted with BuOH (400 ml, under magnetic stirring overnight at room
temperature). After centrifugation (4,000 rpm, 10 min) the buthanolic phase
was dried, redissolved in 50 ml MeOH:H2O 1:1, and resolved by medium
pressure chromatography on 30 g of reversed phase Biotage Snap Cartridge
KP-C18-HS using a CombiFlash RF Teledyne Isco Medium Pressure Chro-
matography System. The column was previously conditioned for 1 min at
20 ml/min with pure water, then brought to 40% of acetonitrile in 5 min, suc-
cessively brought to 60% of acetonitrile in 13 min, and washed with 95% of
acetonitrile for 2 min. The fractions containing compound 6 (HPLC retention
time 17.83 min) were pooled and concentrated under vacuum.
For compounds 7 and 8, 400 ml cultures were mixed with 1 vol MeOH and
stirred at room temperature for 2 hr. Mycelium was removed by centrifugation1077, August 22, 2013 ª2013 Elsevier Ltd All rights reserved 1075
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Intermediates along GE2270 Biosynthesisand the hydroalcoholic extract, after 23 concentration under vacuum, was
extracted with 350 ml butanol for 30 min at room temperature. The resulting
butanolic phase was dried, dissolved in 25 ml H2O:acetonitrile 75:25, and
resolved by medium pressure chromatography on 30 g of reversed phase
Biotage Snap Cartridge KP-C18-HS by using a CombiFlash RF Teledyne
Isco Medium Pressure Chromatography System. The column was previously
conditioned for 1 min at 20 ml/min with H2O, then brought to 40% of acetoni-
trile in 5 min, successively brought to 60% acetonitrile in 13 min, and washed
with 95% of acetonitrile for 2 min. The fractions containing compound 7 or
compound 8 were pooled and concentrated under vacuum.
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